{{Rsnum
|rsid = 28587567
|Status = Merged
|Merged = 2066715
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=9
|position=104825752
|Gene=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 16.8 | 83.2
| HCB | 13.9 | 56.2 | 29.9
| JPT | 11.5 | 46.9 | 41.6
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 3.5 | 96.5
| CHB | 13.9 | 56.2 | 29.9
| CHD | 14.8 | 51.9 | 33.3
| GIH | 1.0 | 6.9 | 92.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 1.7 | 3.4 | 94.8
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 12.7 | 87.3
| HapMapRevision=28
}}{{Venter SNP
|rsid=28587567
|allele=T
|frequency=
|uid=1103652149292
|type=heterozygous_SNP
|hugo=ABCA1
|ensembl gene=ENSG00000165029
|ensembl transcript=ENST00000297693
|sift=TOLERATED
|disease=Defects in ABCA1 are a cause of high density lipoprotein deficiency type 2 (HDLD2) (MIM:604091); also known as familial hypoalphalipoproteinemia (FHA). HDLD2 is inherited as autosomal dominant trait. It is characterized by moderately low HDL cholesterol, predilection toward premature coronary artery disease (CAD) and a reduction in cellular cholesterol efflux.
}}

{{on chip | Affy GenomeWide 6}}